{"as_of":"2026-08-17T04:54:00Z","caps":{"database_statements":6,"inbound":100,"outbound":100},"context_digest":"sha256:e19043d8602c0d1756609b67b453703c3c76832a60ad63704dccff35df51b800","coverage":[{"denominator":0,"lane":"reference_resolution","note":"Typed states for the displayed outbound observations.","records_observed":0,"source":"paper_references, paper_reference_links","source_observed_at":null,"state":"measured"},{"denominator":20,"lane":"standing_notices","note":"One-hop event checks from named stored sources.","records_observed":20,"source":"scholarly_work_events, retraction_status_cache","source_observed_at":"2026-08-16T06:30:59.297886+00:00","state":"measured"},{"denominator":20,"lane":"inbound_itemization","note":"Pith citing papers itemized under the disclosed page cap.","records_observed":20,"source":"paper_references, paper_reference_links","source_observed_at":"2026-08-15T22:25:04.910549Z","state":"measured"},{"denominator":1,"lane":"external_citation_measurements","note":"A source-named dated measurement, never combined with another source.","records_observed":0,"source":"arxiv_reference","source_observed_at":"2026-07-01T16:55:50.484601Z","state":"measured"}],"external_citation_measurements":[],"inbound":[{"citation":{"cited_paper":{"arxiv_id":"2210.13695","last_updated":"2024-09-23T19:31:01Z","snapshot_observed_at":"2026-08-16T16:21:36.041613Z","submitted_at":"2022-10-24T15:51:21Z","title":"Structure-based Drug Design with Equivariant Diffusion Models","version":3},"cited_work":{"arxiv_id":"2210.13695","doi":null,"metadata_source":"arxiv_reference","pith_arxiv_id":"2210.13695","snapshot_observed_at":"2026-07-01T16:55:50.484601Z","title":"Structure-based drug design with equivariant diffusion models","venue":null,"work_id":"84aa7db1-7982-43e6-b149-f52f5210d325","year":2022},"citing_paper":{"arxiv_id":"2406.12910","last_updated":"2024-06-13T01:06:03Z","snapshot_observed_at":"2026-07-06T18:33:11.370375Z","submitted_at":"2024-06-13T01:06:03Z","title":"Human-level molecular optimization driven by mol-gene evolution","version":1},"reference_index":12,"source":"pdf_text","source_observed_at":"2026-05-24T00:29:55.715458Z"},"links":{"cited_paper":"/paper/2210.13695","citing_paper":"/paper/2406.12910"},"observation_digest":"sha256:dc48c8528e67afa018a79a24b2d385f8c04f242ca55ed6af348aa0aa70f4d9c7","observation_id":"9a4faa3b-47d7-4899-b6a3-8069635f9278","resolution":{"observed_at":"2026-05-24T00:33:40.084011Z","resolver_source":"arxiv_id","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-16T06:30:59.297886+00:00","source":"crossref"},{"observed_at":"2026-08-16T06:30:54.164669+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2210.13695","last_updated":"2024-09-23T19:31:01Z","snapshot_observed_at":"2026-08-16T16:21:36.041613Z","submitted_at":"2022-10-24T15:51:21Z","title":"Structure-based Drug Design with Equivariant Diffusion Models","version":3},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2210.13695","snapshot_observed_at":"2026-08-12T16:45:02.940467Z","title":"Schneuing, A., Du, Y ., Harris, C., Jamasb, A., Igashov, I., Du, W., Blundell, T., Lió, P., Gomes, C., Welling, M., Bronstein, M., and Correia, B","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2411.13280","last_updated":"2025-06-05T12:35:30Z","snapshot_observed_at":"2026-08-15T04:05:58.338658Z","submitted_at":"2024-11-20T12:48:29Z","title":"Empower Structure-Based Molecule Optimization with Gradient Guided Bayesian Flow Networks","version":4},"reference_index":2024,"source":"pdf_text","source_observed_at":"2026-08-12T16:45:02.940467Z"},"links":{"cited_paper":"/paper/2210.13695","citing_paper":"/paper/2411.13280"},"observation_digest":"sha256:5ed157cdf4073814efdc4e706a79fcfa15eb18505a7303393b4c8cb8a7eab6b2","observation_id":"f029884a-e7f5-4774-94fa-0ea280656f8e","resolution":{"observed_at":"2026-08-12T16:45:02.940467Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2210.13695","last_updated":"2024-09-23T19:31:01Z","snapshot_observed_at":"2026-08-16T16:21:36.041613Z","submitted_at":"2022-10-24T15:51:21Z","title":"Structure-based Drug Design with Equivariant Diffusion Models","version":3},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2210.13695","snapshot_observed_at":"2026-08-12T12:56:55.016817Z","title":"Structure-based Drug Design with Equivariant Diffusion Models, June 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2411.16644","last_updated":"2024-11-25T18:27:39Z","snapshot_observed_at":"2026-08-16T18:56:24.300916Z","submitted_at":"2024-11-25T18:27:39Z","title":"Exploring Discrete Flow Matching for 3D De Novo Molecule Generation","version":1},"reference_index":3,"source":"pdf_text","source_observed_at":"2026-08-12T12:56:55.016817Z"},"links":{"cited_paper":"/paper/2210.13695","citing_paper":"/paper/2411.16644"},"observation_digest":"sha256:0210fe8f25d8df1846e99f7a6b7f18724e6d9553c9544847b226c0ae1b18b0ca","observation_id":"dde2a605-7f86-4e10-9bb6-37a7fcac384a","resolution":{"observed_at":"2026-08-12T12:56:55.016817Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2210.13695","last_updated":"2024-09-23T19:31:01Z","snapshot_observed_at":"2026-08-16T16:21:36.041613Z","submitted_at":"2022-10-24T15:51:21Z","title":"Structure-based Drug Design with Equivariant Diffusion Models","version":3},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2210.13695","snapshot_observed_at":"2026-08-11T18:44:52.113989Z","title":"9 PharmacophoreBridge Structure-based drug design with equivariant diffusion models","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2412.19812","last_updated":"2025-01-27T05:43:48Z","snapshot_observed_at":"2026-08-16T13:27:53.306222Z","submitted_at":"2024-12-10T15:41:06Z","title":"Pharmacophore-guided de novo drug design with diffusion bridge","version":2},"reference_index":10,"source":"pdf_text","source_observed_at":"2026-08-11T18:44:52.113989Z"},"links":{"cited_paper":"/paper/2210.13695","citing_paper":"/paper/2412.19812"},"observation_digest":"sha256:bb614b7d351ce7cde5b9e0ca2eb40a853fcc9b3727643578d8f7ec6a202c7517","observation_id":"c95356ac-e992-4d77-ad20-2a66e3cb1ddd","resolution":{"observed_at":"2026-08-11T18:44:52.113989Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2210.13695","last_updated":"2024-09-23T19:31:01Z","snapshot_observed_at":"2026-08-16T16:21:36.041613Z","submitted_at":"2022-10-24T15:51:21Z","title":"Structure-based Drug Design with Equivariant Diffusion Models","version":3},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2210.13695","snapshot_observed_at":"2026-08-10T14:09:57.675908Z","title":"Structure-based drug design with equivariant diffusion models","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2501.15631","last_updated":"2025-01-26T18:29:11Z","snapshot_observed_at":"2026-08-15T10:04:23.934788Z","submitted_at":"2025-01-26T18:29:11Z","title":"BoKDiff: Best-of-K Diffusion Alignment for Target-Specific 3D Molecule Generation","version":1},"reference_index":22,"source":"pdf_text","source_observed_at":"2026-08-10T14:09:57.675908Z"},"links":{"cited_paper":"/paper/2210.13695","citing_paper":"/paper/2501.15631"},"observation_digest":"sha256:0cdd99d26c43497570297efa2256d237661cab92e0eca89d06cdaf23bb3b4660","observation_id":"cf95e5c9-74c6-4dad-93f0-608b78fe7847","resolution":{"observed_at":"2026-08-10T14:09:57.675908Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2210.13695","last_updated":"2024-09-23T19:31:01Z","snapshot_observed_at":"2026-08-16T16:21:36.041613Z","submitted_at":"2022-10-24T15:51:21Z","title":"Structure-based Drug Design with Equivariant Diffusion Models","version":3},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2210.13695","snapshot_observed_at":"2026-08-08T20:18:09.958049Z","title":"Structure-based drug design with equivariant diffusion models","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-11T18:20:46.807995Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":69,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.958049Z"},"links":{"cited_paper":"/paper/2210.13695","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:cfc42643435fc126abf0e65b254978550fbe6328e7853b1cc10995ee106a78f2","observation_id":"346c372c-bac4-46a2-83e9-800f59cf6b2e","resolution":{"observed_at":"2026-08-08T20:18:09.958049Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2210.13695","last_updated":"2024-09-23T19:31:01Z","snapshot_observed_at":"2026-08-16T16:21:36.041613Z","submitted_at":"2022-10-24T15:51:21Z","title":"Structure-based Drug Design with Equivariant Diffusion Models","version":3},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2210.13695","snapshot_observed_at":"2026-08-08T17:03:39.292805Z","title":null,"venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2502.06027","last_updated":"2025-02-09T20:50:39Z","snapshot_observed_at":"2026-08-15T10:27:34.319120Z","submitted_at":"2025-02-09T20:50:39Z","title":"Generating 3D Binding Molecules Using Shape-Conditioned Diffusion Models with Guidance","version":1},"reference_index":12,"source":"pdf_text","source_observed_at":"2026-08-08T17:03:39.292805Z"},"links":{"cited_paper":"/paper/2210.13695","citing_paper":"/paper/2502.06027"},"observation_digest":"sha256:83b5f60976bb4d041e768e5971caaca976f4f2dd0732a00c6ab80857d841089f","observation_id":"60f1370d-18d6-42a9-af51-93d30f423edf","resolution":{"observed_at":"2026-08-08T17:03:39.292805Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2210.13695","last_updated":"2024-09-23T19:31:01Z","snapshot_observed_at":"2026-08-16T16:21:36.041613Z","submitted_at":"2022-10-24T15:51:21Z","title":"Structure-based Drug Design with Equivariant Diffusion Models","version":3},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2210.13695","snapshot_observed_at":"2026-08-15T22:25:04.910549Z","title":"Structure-based Drug Design with Equivariant Diffusion Models , October 2022","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2505.07286","last_updated":"2025-06-05T12:37:46Z","snapshot_observed_at":"2026-08-15T22:18:08.737413Z","submitted_at":"2025-05-12T07:18:09Z","title":"Piloting Structure-Based Drug Design via Modality-Specific Optimal Schedule","version":2},"reference_index":27,"source":"arxiv_source","source_observed_at":"2026-08-15T22:25:04.910549Z"},"links":{"cited_paper":"/paper/2210.13695","citing_paper":"/paper/2505.07286"},"observation_digest":"sha256:cc48ecd3abb91d69f37e3dacea4d74c0e8b75e72a4dc7a4b085871c458a006b5","observation_id":"361d7e76-ac03-4e00-a493-576e07a2ec4c","resolution":{"observed_at":"2026-08-15T22:25:04.910549Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2210.13695","last_updated":"2024-09-23T19:31:01Z","snapshot_observed_at":"2026-08-16T16:21:36.041613Z","submitted_at":"2022-10-24T15:51:21Z","title":"Structure-based Drug Design with Equivariant Diffusion Models","version":3},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2210.13695","snapshot_observed_at":"2026-08-07T14:36:01.476036Z","title":"Structure-based drug design with equivariant diffusion models","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2505.18392","last_updated":"2025-05-23T21:41:56Z","snapshot_observed_at":"2026-08-17T02:05:54.373405Z","submitted_at":"2025-05-23T21:41:56Z","title":"Applications of Modular Co-Design for De Novo 3D Molecule Generation","version":1},"reference_index":36,"source":"arxiv_source","source_observed_at":"2026-08-07T14:36:01.476036Z"},"links":{"cited_paper":"/paper/2210.13695","citing_paper":"/paper/2505.18392"},"observation_digest":"sha256:0cbbbc81d61e0076d52ff92ca523772b35445423e7069624f71896b648ef4dba","observation_id":"bfba4c89-014d-45be-89e6-911e9a69bcff","resolution":{"observed_at":"2026-08-07T14:36:01.476036Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2210.13695","last_updated":"2024-09-23T19:31:01Z","snapshot_observed_at":"2026-08-16T16:21:36.041613Z","submitted_at":"2022-10-24T15:51:21Z","title":"Structure-based Drug Design with Equivariant Diffusion Models","version":3},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2210.13695","snapshot_observed_at":"2026-08-07T05:50:58.722321Z","title":"Structure -based drug design with equivariant diffusion models","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2506.06915","last_updated":"2025-06-07T20:29:59Z","snapshot_observed_at":"2026-08-15T02:55:29.707992Z","submitted_at":"2025-06-07T20:29:59Z","title":"Graph Neural Networks in Modern AI-aided Drug Discovery","version":1},"reference_index":64,"source":"pdf_text","source_observed_at":"2026-08-07T05:50:58.722321Z"},"links":{"cited_paper":"/paper/2210.13695","citing_paper":"/paper/2506.06915"},"observation_digest":"sha256:bea423b961c80da8fb9f415dc5c52730e9bd85dbff6cb6280cd762092e46ef53","observation_id":"ed107185-f82f-4756-b48d-c3e0a850cc0e","resolution":{"observed_at":"2026-08-07T05:50:58.722321Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2210.13695","last_updated":"2024-09-23T19:31:01Z","snapshot_observed_at":"2026-08-16T16:21:36.041613Z","submitted_at":"2022-10-24T15:51:21Z","title":"Structure-based Drug Design with Equivariant Diffusion Models","version":3},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2210.13695","snapshot_observed_at":"2026-08-06T21:12:00.177338Z","title":"Structure-based drug design with equivariant diffusion models","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2507.00899","last_updated":"2025-07-01T16:01:58Z","snapshot_observed_at":"2026-08-09T03:52:42.297017Z","submitted_at":"2025-07-01T16:01:58Z","title":"TABASCO: A Fast, Simplified Model for Molecular Generation with Improved Physical Quality","version":1},"reference_index":23,"source":"arxiv_source","source_observed_at":"2026-08-06T21:12:00.177338Z"},"links":{"cited_paper":"/paper/2210.13695","citing_paper":"/paper/2507.00899"},"observation_digest":"sha256:87eca81a4dda3600d73aa5d8002888bd9b96a26d6be16966d60a1169f01879d5","observation_id":"95fd5143-bf5b-4712-ace6-e178c11557af","resolution":{"observed_at":"2026-08-06T21:12:00.177338Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2210.13695","last_updated":"2024-09-23T19:31:01Z","snapshot_observed_at":"2026-08-16T16:21:36.041613Z","submitted_at":"2022-10-24T15:51:21Z","title":"Structure-based Drug Design with Equivariant Diffusion Models","version":3},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2210.13695","snapshot_observed_at":"2026-08-15T17:25:08.231582Z","title":"Schneuing, Y","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2508.12629","last_updated":"2025-08-18T05:13:27Z","snapshot_observed_at":"2026-08-15T19:30:02.375553Z","submitted_at":"2025-08-18T05:13:27Z","title":"FlowMol3: Flow Matching for 3D De Novo Small-Molecule Generation","version":1},"reference_index":3,"source":"arxiv_source","source_observed_at":"2026-08-15T17:25:08.231582Z"},"links":{"cited_paper":"/paper/2210.13695","citing_paper":"/paper/2508.12629"},"observation_digest":"sha256:8845a5f7b6b91a77d7bbab11a0608c72606a884115a389a0c2f248017e10fac8","observation_id":"4813ff7c-a036-4982-9baa-e46e2d2591e7","resolution":{"observed_at":"2026-08-15T17:25:08.231582Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2210.13695","last_updated":"2024-09-23T19:31:01Z","snapshot_observed_at":"2026-08-16T16:21:36.041613Z","submitted_at":"2022-10-24T15:51:21Z","title":"Structure-based Drug Design with Equivariant Diffusion Models","version":3},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2210.13695","snapshot_observed_at":"2026-08-15T17:05:01.439541Z","title":"Structure-based drug design with equivariant diffusion models","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2508.17815","last_updated":"2025-08-25T09:12:01Z","snapshot_observed_at":"2026-08-15T16:58:11.904790Z","submitted_at":"2025-08-25T09:12:01Z","title":"Multi-domain Distribution Learning for De Novo Drug Design","version":1},"reference_index":24,"source":"pdf_text","source_observed_at":"2026-08-15T17:05:01.439541Z"},"links":{"cited_paper":"/paper/2210.13695","citing_paper":"/paper/2508.17815"},"observation_digest":"sha256:3e5be7767f7b6a2f1e7bdf3aa8b95532fce6c8127ab55b70626c36d03a4ea7cb","observation_id":"96b97481-1da9-434a-ba77-83f9d72de786","resolution":{"observed_at":"2026-08-15T17:05:01.439541Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2210.13695","last_updated":"2024-09-23T19:31:01Z","snapshot_observed_at":"2026-08-16T16:21:36.041613Z","submitted_at":"2022-10-24T15:51:21Z","title":"Structure-based Drug Design with Equivariant Diffusion Models","version":3},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2210.13695","snapshot_observed_at":"2026-08-04T12:42:54.882208Z","title":"Structure-based drug design with equivariant diffusion models, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2510.02578","last_updated":"2026-05-29T09:31:11Z","snapshot_observed_at":"2026-08-14T03:44:09.138590Z","submitted_at":"2025-10-02T21:38:26Z","title":"FLOWR.root: A flow matching based foundation model for joint multi-purpose structure-aware 3D ligand generation and affinity prediction","version":6},"reference_index":93,"source":"arxiv_source","source_observed_at":"2026-08-04T12:42:54.882208Z"},"links":{"cited_paper":"/paper/2210.13695","citing_paper":"/paper/2510.02578"},"observation_digest":"sha256:c7b6631fcae80b11289d08183a9f14a3da0a0609d6dde5e8b7f9e7acef2ec495","observation_id":"fd82c09a-749b-49ca-9b29-9bf46ca531cb","resolution":{"observed_at":"2026-08-04T12:42:54.882208Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2210.13695","last_updated":"2024-09-23T19:31:01Z","snapshot_observed_at":"2026-08-16T16:21:36.041613Z","submitted_at":"2022-10-24T15:51:21Z","title":"Structure-based Drug Design with Equivariant Diffusion Models","version":3},"cited_work":{"arxiv_id":"2210.13695","doi":null,"metadata_source":"arxiv_reference","pith_arxiv_id":"2210.13695","snapshot_observed_at":"2026-07-01T16:55:50.484601Z","title":"Structure-based drug design with equivariant diffusion models","venue":null,"work_id":"84aa7db1-7982-43e6-b149-f52f5210d325","year":2022},"citing_paper":{"arxiv_id":"2604.19562","last_updated":"2026-04-21T15:13:41Z","snapshot_observed_at":"2026-08-15T21:18:53.185550Z","submitted_at":"2026-04-21T15:13:41Z","title":"Structure-guided molecular design with contrastive 3D protein-ligand learning","version":1},"reference_index":11,"source":"arxiv_source","source_observed_at":"2026-05-10T02:29:31.970472Z"},"links":{"cited_paper":"/paper/2210.13695","citing_paper":"/paper/2604.19562"},"observation_digest":"sha256:ff865e89575a39fbd70e42e78f2d8386dc6265aaadf8598ef814b869c1f24cb5","observation_id":"c6e5f663-a2e7-42ab-8c2a-b60d0dca148b","resolution":{"observed_at":"2026-05-11T13:01:04.930128Z","resolver_source":"arxiv_id","status":"metadata_mismatch"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-16T06:30:59.297886+00:00","source":"crossref"},{"observed_at":"2026-08-16T06:30:54.164669+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2210.13695","last_updated":"2024-09-23T19:31:01Z","snapshot_observed_at":"2026-08-16T16:21:36.041613Z","submitted_at":"2022-10-24T15:51:21Z","title":"Structure-based Drug Design with Equivariant Diffusion Models","version":3},"cited_work":{"arxiv_id":"2210.13695","doi":null,"metadata_source":"arxiv_reference","pith_arxiv_id":"2210.13695","snapshot_observed_at":"2026-07-01T16:55:50.484601Z","title":"Structure-based drug design with equivariant diffusion models","venue":null,"work_id":"84aa7db1-7982-43e6-b149-f52f5210d325","year":2022},"citing_paper":{"arxiv_id":"2605.03205","last_updated":"2026-05-04T22:48:45Z","snapshot_observed_at":"2026-08-13T04:52:23.520760Z","submitted_at":"2026-05-04T22:48:45Z","title":"From Knowledge to Action: Outcomes of the 2025 Large Language Model (LLM) Hackathon for Applications in Materials Science and Chemistry","version":1},"reference_index":146,"source":"pdf_text","source_observed_at":"2026-05-08T17:38:30.092429Z"},"links":{"cited_paper":"/paper/2210.13695","citing_paper":"/paper/2605.03205"},"observation_digest":"sha256:f35df3b263d940ad109c406aefc905f577d3865e1b116626e52c37579be47d15","observation_id":"049e6a8d-1e1e-46ce-bef0-cc3735a00540","resolution":{"observed_at":"2026-05-11T17:21:10.320266Z","resolver_source":"arxiv_id","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-16T06:30:59.297886+00:00","source":"crossref"},{"observed_at":"2026-08-16T06:30:54.164669+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2210.13695","last_updated":"2024-09-23T19:31:01Z","snapshot_observed_at":"2026-08-16T16:21:36.041613Z","submitted_at":"2022-10-24T15:51:21Z","title":"Structure-based Drug Design with Equivariant Diffusion Models","version":3},"cited_work":{"arxiv_id":"2210.13695","doi":null,"metadata_source":"arxiv_reference","pith_arxiv_id":"2210.13695","snapshot_observed_at":"2026-07-01T16:55:50.484601Z","title":"Structure-based drug design with equivariant diffusion models","venue":null,"work_id":"84aa7db1-7982-43e6-b149-f52f5210d325","year":2022},"citing_paper":{"arxiv_id":"2605.26540","last_updated":"2026-08-06T10:54:40Z","snapshot_observed_at":"2026-08-14T12:33:19.230002Z","submitted_at":"2026-05-26T04:43:45Z","title":"Domain-Gated Latent Diffusion: Generative Inverse Design of HMX-Class Energetic Materials with First-Principles Validation","version":1},"reference_index":45,"source":"pdf_text","source_observed_at":"2026-07-01T16:52:26.323828Z"},"links":{"cited_paper":"/paper/2210.13695","citing_paper":"/paper/2605.26540"},"observation_digest":"sha256:15e9df106d65a0fc0209aa67a762e90b0de88c3863988df868e394e1977ae099","observation_id":"6bf864d2-c996-4699-8b9d-bd91bad9fd51","resolution":{"observed_at":"2026-07-01T16:55:50.486175Z","resolver_source":"arxiv_id","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-16T06:30:59.297886+00:00","source":"crossref"},{"observed_at":"2026-08-16T06:30:54.164669+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2210.13695","last_updated":"2024-09-23T19:31:01Z","snapshot_observed_at":"2026-08-16T16:21:36.041613Z","submitted_at":"2022-10-24T15:51:21Z","title":"Structure-based Drug Design with Equivariant Diffusion Models","version":3},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2210.13695","snapshot_observed_at":"2026-07-12T06:44:20.438683Z","title":"Structure-based Drug Design with Equivariant Diffusion Models, October 2022","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2607.02834","last_updated":"2026-07-03T00:06:31Z","snapshot_observed_at":"2026-08-16T20:33:56.104879Z","submitted_at":"2026-07-03T00:06:31Z","title":"On the Design Space of Discrete Diffusion Online Adaptation for Molecular Optimization","version":1},"reference_index":38,"source":"pdf_text","source_observed_at":"2026-07-12T06:44:20.438683Z"},"links":{"cited_paper":"/paper/2210.13695","citing_paper":"/paper/2607.02834"},"observation_digest":"sha256:3ce958905aceb5a5367b5033f80cc1774d73b7e4e3966e7ed5f7631c7cbdb5b1","observation_id":"b97d9bcb-4555-4ec8-aba8-1dccb3abc3a4","resolution":{"observed_at":"2026-07-12T06:44:20.438683Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2210.13695","last_updated":"2024-09-23T19:31:01Z","snapshot_observed_at":"2026-08-16T16:21:36.041613Z","submitted_at":"2022-10-24T15:51:21Z","title":"Structure-based Drug Design with Equivariant Diffusion Models","version":3},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2210.13695","snapshot_observed_at":"2026-08-01T22:02:30.578930Z","title":"Structure-based Drug Design with Equivariant Dif- fusion Models.Nature Computational Science, 4 (12):899–909, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2607.15918","last_updated":"2026-07-17T12:48:57Z","snapshot_observed_at":"2026-08-15T02:56:08.147875Z","submitted_at":"2026-07-17T12:48:57Z","title":"Atomic Design Transformer: Scaffold-Conditioned 3D Molecule Generation via xTB-Reward Reinforcement Learning","version":1},"reference_index":16,"source":"pdf_text","source_observed_at":"2026-08-01T22:02:30.578930Z"},"links":{"cited_paper":"/paper/2210.13695","citing_paper":"/paper/2607.15918"},"observation_digest":"sha256:b8e9eb71c62d2a2b9cb53b60dfd8ce9aa2487af3839fcd2a4fb22ab7f8d9e18c","observation_id":"319b2f29-b7ce-4ed4-b73d-6f67c859773c","resolution":{"observed_at":"2026-08-01T22:02:30.578930Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2210.13695","last_updated":"2024-09-23T19:31:01Z","snapshot_observed_at":"2026-08-16T16:21:36.041613Z","submitted_at":"2022-10-24T15:51:21Z","title":"Structure-based Drug Design with Equivariant Diffusion Models","version":3},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2210.13695","snapshot_observed_at":"2026-08-01T12:34:59.701201Z","title":null,"venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2607.19519","last_updated":"2026-07-21T19:08:50Z","snapshot_observed_at":"2026-08-16T08:58:28.266699Z","submitted_at":"2026-07-21T19:08:50Z","title":"Boltzmann-Expected Molecular Design with Decoupled Annealing Flows","version":1},"reference_index":71,"source":"pdf_text","source_observed_at":"2026-08-01T12:34:59.701201Z"},"links":{"cited_paper":"/paper/2210.13695","citing_paper":"/paper/2607.19519"},"observation_digest":"sha256:b0c7c1a29b02095705dd4d3177e8942df58ad8fe322a4a184c558bf305d0063c","observation_id":"a63b1972-8b89-48ee-af6d-f14a808c8db2","resolution":{"observed_at":"2026-08-01T12:34:59.701201Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}}],"links":{"evidence":"/evidence","html":"/paper/2210.13695/citation-record","integrity":"/paper/2210.13695/integrity","json":"/paper/2210.13695/citation-record.json","paper":"/paper/2210.13695"},"outbound":[],"paper":{"arxiv_id":"2210.13695","last_updated":"2024-09-23T19:31:01Z","latest_version":3,"primary_category":"q-bio.BM","snapshot_observed_at":"2026-08-16T16:21:36.041613Z","submitted_at":"2022-10-24T15:51:21Z","title":"Structure-based Drug Design with Equivariant Diffusion Models"},"reference_resolution":{"displayed":0,"state_counts":{"malformed_identifier":0,"metadata_mismatch":0,"parse_uncertain":0,"unresolved":0,"verified_exact":0,"verified_fuzzy":0},"total_outbound_references":0},"refusal":"A citation records a reference. It does not transfer a finding from one paper to another.","schema":"pith.paper-citation-record.v1","standing_sources":[{"observed_at":"2026-08-16T06:30:59.297886+00:00","source":"crossref"},{"observed_at":"2026-08-16T06:30:54.164669+00:00","source":"retraction_watch"}],"thesis":"As of 17 August 2026, this Paper Citation Record lists 0 of 0 outbound references and 20 inbound Pith citation observations for arXiv:2210.13695."}